CD44 and breast carcinoma: In contrast, forced expression of miR-100 and miR-221in MCF10A, a non-tumorigenic breast cell line, as well as a variety of tumorigenic breast cancer cell lines resulted in the induction of CD24-CD44+ EMT stem cells and decreased proportion of ALDH+ MET stem cells [115].